Show simple item record

Evaluation of extended and continuous use oral contraceptives

dc.contributor.authorWright, Kristen Page
dc.contributor.authorJohnson, Julia V.
dc.date2022-08-11T08:10:06.000
dc.date.accessioned2022-08-23T16:56:04Z
dc.date.available2022-08-23T16:56:04Z
dc.date.issued2008-10-01
dc.date.submitted2013-02-07
dc.identifier.citation<p>Wright KP, Johnson JV. Evaluation of extended and continuous use oral contraceptives. Ther Clin Risk Manag. 2008 Oct;4(5):905-11. doi: 10.2147/tcrm.s2143. PMID: 19209272; PMCID: PMC2621397. <a href="http://dx.doi.org/10.2147/TCRM.S2143">Link to article on publisher's website</a></p>
dc.identifier.issn1176-6336 (Linking)
dc.identifier.doi10.2147/TCRM.S2143
dc.identifier.pmid19209272
dc.identifier.urihttp://hdl.handle.net/20.500.14038/42848
dc.description<p>At the time of publication, Julia Johnson was not yet affiliated with the University of Massachusetts Medical School.</p>
dc.description.abstractOral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every day (continuous). These concepts are not new; extended and continuous pills were first studied in the 1960s and 1970s and have been provided in an off-label manner by gynecologists to treat menstrual disorders, such as menorrhagia and dysmenorrhea, and gynecologic disorders, such as endometriosis. Now that extended and continuous combined oral contraceptives are available for all patients, it is critical for providers to understand the physiology, dosing, side effects, and benefits of this form of oral contraceptive. This article reviews the history and the potential uses of the new continuous combined oral contraceptive.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=19209272&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttp://dx.doi.org/10.2147/TCRM.S2143
dc.rights© 2008 Dove Medical Press Limited. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/
dc.subjectContraceptives, Oral
dc.subjectoral contraceptives
dc.subjectadministration
dc.subjectdosage
dc.subjectadverse effects
dc.subjectmenstrual disturbances
dc.subjectObstetrics and Gynecology
dc.subjectWomen's Health
dc.titleEvaluation of extended and continuous use oral contraceptives
dc.typeJournal Article
dc.source.journaltitleTherapeutics and clinical risk management
dc.source.volume4
dc.source.issue5
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1061&amp;context=obgyn_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/obgyn_pp/62
dc.legacy.embargo2013-02-07T00:00:00-08:00
dc.identifier.contextkey3664608
refterms.dateFOA2022-08-23T16:56:04Z
html.description.abstract<p>Oral contraceptives are classically given in a cyclic manner with 21 days of active pills followed by 7 days of placebo. In the past 4 years, new oral contraceptives have been introduced which either shorten the placebo time, lengthen the active pills (extended cycle), or provide active pills every day (continuous). These concepts are not new; extended and continuous pills were first studied in the 1960s and 1970s and have been provided in an off-label manner by gynecologists to treat menstrual disorders, such as menorrhagia and dysmenorrhea, and gynecologic disorders, such as endometriosis. Now that extended and continuous combined oral contraceptives are available for all patients, it is critical for providers to understand the physiology, dosing, side effects, and benefits of this form of oral contraceptive. This article reviews the history and the potential uses of the new continuous combined oral contraceptive.</p>
dc.identifier.submissionpathobgyn_pp/62
dc.contributor.departmentDepartment of Obstetrics and Gynecology
dc.source.pages905-11


Files in this item

Thumbnail
Name:
Dove_Press_TCRM_2008_4_5__2143 ...
Size:
75.73Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record

© 2008 Dove Medical Press Limited. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Except where otherwise noted, this item's license is described as © 2008 Dove Medical Press Limited. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.